glp-1 news october 9 2025 GLP-1s for Weight Loss: What You Need to Know Looming GLP-1 drug patent expirations

lactis HN019 was also shown to reduce transit time and relieve symptoms compared with placebo in a trial with 100 participants whose average stool frequency at baseline was 13 per week

However, it is unclear exactly which isoform acts in cardiomyocytes and how it exerts its anti-ferroptosis effect, which requires further study

It is not a cure for obesity, but it can help you lose weight

Lab work Comprehensive metabolic, hormonal, and inflammatory panel

Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features

If you have any concerns or experience unusual symptoms, stop use and speak with your doctor, especially during pregnancy.